Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

"We are pleased to work with Dr. Rabkin and the team at Brigham and Women's Hospital on this clinical study." commented Harel Gadot, CEO, President and Chairman of Microbot Medical. "We believe their commitment to research and the advancement of science make them an ideal clinical study site." Microbot Medical Inc. (NASDAQ:MBOT) is a clinical- stage medical device company that specializes in transformational micro-robotic technologies, with the goals of improving clinical outcomes for patients and increasin ...